Key Points
- CTO Raymond Woo sold 11,112 shares on April 1 at an average price of $18.56 under a pre‑arranged Rule 10b5‑1 plan, generating about $206,239 and reducing his stake by 6.24% to 166,912 shares (≈$3.10M).
- Woo made additional recent sales—8,087 shares on March 2 at $18.25 and 705 shares on February 23 at $19.79—signaling continued pre‑arranged insider selling activity.
- CeriBell (CBLL) has a market cap of roughly $699M and a 52‑week range of $10.01–$24.33, is currently loss‑making (negative EPS and margins), and carries an average analyst rating of "Moderate Buy" with a $23.20 price target.
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) CTO Raymond Woo sold 11,112 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $18.56, for a total transaction of $206,238.72. Following the sale, the chief technology officer owned 166,912 shares of the company's stock, valued at approximately $3,097,886.72. This represents a 6.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Raymond Woo also recently made the following trade(s):
- On Monday, March 2nd, Raymond Woo sold 8,087 shares of CeriBell stock. The shares were sold at an average price of $18.25, for a total transaction of $147,587.75.
- On Monday, February 23rd, Raymond Woo sold 705 shares of CeriBell stock. The shares were sold at an average price of $19.79, for a total transaction of $13,951.95.
CeriBell Price Performance
Shares of CBLL opened at $18.57 on Friday. CeriBell, Inc. has a fifty-two week low of $10.01 and a fifty-two week high of $24.33. The company has a market capitalization of $698.97 million, a price-to-earnings ratio of -12.63 and a beta of 0.94. The firm has a 50-day simple moving average of $19.31 and a 200-day simple moving average of $17.41. The company has a debt-to-equity ratio of 0.13, a quick ratio of 9.35 and a current ratio of 9.73.
CeriBell (NASDAQ:CBLL - Get Free Report) last issued its quarterly earnings results on Tuesday, February 24th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.43) by $0.07. The firm had revenue of $24.78 million for the quarter, compared to analysts' expectations of $23.95 million. CeriBell had a negative return on equity of 31.77% and a negative net margin of 59.97%. On average, equities research analysts anticipate that CeriBell, Inc. will post -2.46 earnings per share for the current year.
Analyst Ratings Changes
A number of research analysts have recently issued reports on CBLL shares. TD Cowen reissued a "buy" rating on shares of CeriBell in a report on Tuesday, December 9th. BTIG Research reiterated a "buy" rating and issued a $30.00 price objective on shares of CeriBell in a research report on Wednesday, January 28th. Finally, Canaccord Genuity Group boosted their price objective on shares of CeriBell from $29.00 to $30.00 and gave the company a "buy" rating in a research note on Wednesday, December 17th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $23.20.
View Our Latest Stock Report on CeriBell
Hedge Funds Weigh In On CeriBell
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd raised its stake in shares of CeriBell by 3,971.0% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company's stock worth $28,000 after buying an additional 1,231 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of CeriBell in the third quarter valued at approximately $33,000. CWM LLC boosted its stake in shares of CeriBell by 1,178.5% in the fourth quarter. CWM LLC now owns 1,841 shares of the company's stock valued at $40,000 after buying an additional 1,697 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in CeriBell by 353.8% during the second quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company's stock worth $43,000 after acquiring an additional 1,801 shares during the period. Finally, Ameritas Investment Partners Inc. raised its position in CeriBell by 97.5% in the second quarter. Ameritas Investment Partners Inc. now owns 2,544 shares of the company's stock worth $48,000 after acquiring an additional 1,256 shares in the last quarter.
About CeriBell
(
Get Free Report)
CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell's solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.
The company's product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
